The accumulated evidence has revealed that elevated levels of B7H3 in certain human tumours correlate closely with poor clinical outcome including survival, prognosis, and tumour grade33, 34; however, B7H3 also possesses strong antitumour effects34, 35, suggesting the dual functions B7H3 has in tumour immunity. Here, CD276 is linked to neoplasm.